Q97823694

Summary

Q97823694 is an individual motion^[1].

Key Facts

• Q97823694 authored Per Åsling^[2].
• Q97823694's instance of is recorded as individual motion^[3].
• Q97823694's part of the series is recorded as motions of the 2010-2011 legislative session of the Riksdag^[4].
• Q97823694's language of work or name is recorded as Swedish^[5].
• Q97823694 was published on +2010-10-25T00:00:00Z^[6].
• Q97823694's main subject is medication^[7].
• Q97823694's work available at URL is recorded as http://data.riksdagen.se/dokument/GY02So599^[8].
• Q97823694's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GY02So599^[9].
• Q97823694's applies to jurisdiction is recorded as Sweden^[10].
• Q97823694's legal citation of this text is recorded as Mot. 2010/11:So599^[11].
• Q97823694's title is recorded as Angående behovet av fler kliniska läkemedelsprövningar i Sverige^[12].
• Q97823694's cites work is recorded as Q98460569^[13].
• Q97823694's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97823694's copyright status is recorded as public domain^[15].
• Q97823694's legislative committee is recorded as Committee on Health and Welfare^[16].

Body

Definition and Type

Q97823694's instance of is recorded as individual motion^[3].